clofazimine and s 8932

clofazimine has been researched along with s 8932 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Anderson, KS; Cabeza de Vaca, I; Deshmukh, M; Ghahremanpour, MM; Ippolito, JA; Jorgensen, WL; Liosi, ME; Tirado-Rives, J; Zhang, CH1
Au, WK; Cai, XH; Cao, J; Chan, CC; Chan, JF; Chanda, SK; Chen, H; Chu, H; Clausen, TM; Du, Y; Esko, JD; Hung, IF; Jin, DY; Kok, KH; Lai, PM; Lau, CY; Lee, AC; Li, RA; Liang, R; Matsunaga, N; Meng, X; Oh, J; Pache, L; Pihl, J; Poon, VK; Pu, Y; Riva, L; Sheng, L; Sit, KY; Sun, H; Sun, R; Sze, KH; Tang, K; Tang, YD; Wang, D; Wang, R; Xu, W; Ye, ZW; Yin, X; Yuan, S; Yuen, CK; Yuen, KY; Zhang, AJ; Zhang, YY1

Other Studies

2 other study(ies) available for clofazimine and s 8932

ArticleYear
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2.
    ACS medicinal chemistry letters, 2020, Dec-10, Volume: 11, Issue:12

    Topics:

2020
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2.
    Nature, 2021, Volume: 593, Issue:7859

    Topics: Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Antiviral Agents; Biological Availability; Cell Fusion; Cell Line; Clofazimine; Coronavirus; Cricetinae; DNA Helicases; Drug Synergism; Female; Humans; Life Cycle Stages; Male; Mesocricetus; Pre-Exposure Prophylaxis; SARS-CoV-2; Species Specificity; Spike Glycoprotein, Coronavirus; Transcription, Genetic

2021